Search

everythinglearnresearchcommunity

for

Search:↓

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Erythema multiforme-like lesions can occur in lupus without drug use or herpes infection.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Promising cancer treatments were found, but the manufacturer closed.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.